Background Bloodstream infections (BSIs) produced by antibiotic-resistant bacteria (ARB)
cause a substantial disease burden worldwide. However, most estimates come from high …

Purpose: To review the epidemiology of Staphylococcus aureus bacteraemia (SAB) and
endocarditis (SAE), and discuss the short-and long-term outcome. Materials and methods: A …

Background Multiple drug resistance (MDR) in staphylococci, including resistance to the
semi‐synthetic penicillinase‐resistant penicillins such as meticillin, is a problem of global …

Abstract Background The Micra clinical trials have enrolled more than 2500 patients without
any reported device‐related infections that required removal during follow‐up. Leadless …

We aimed to describe the characteristics of patients with Staphylococcus aureus bacteremia
and to evaluate the risk factors associated with early (7-day) and late (30-day) mortality. We …

Objectives We performed a systematic review and meta-analysis to estimate the effect of
early active empirical antibiotics for MRSA on mortality, both in patients admitted with MRSA …

Introduction Bloodstream infections are associated with high mortality rates and contribute
substantially to healthcare costs, but a consensus on the prognostic benefits of appropriate …

Background: Staphylococcus aureus is a common human pathogen capable of causing
diverse illnesses with possible recurrent infections. Although recent studies have highlighted …

Background The use of peripheral venous catheters (PVCs) has increased outside intensive
care units, as has the rate of PVC-associated-bloodstream infection (PVC-BSI). PVCs are …

Abstract Background Glycopeptides (GPs), lipopeptides (LPs) and lipoglycopeptides (LGPs)
are related antimicrobials important for the management of invasive MRSA infections. Cross …